Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1830 | 5658 | 33.4 | 61% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
298 | 36539 | PERMANENCE//ECONOPHYSICS//GLOBAL ATTRACTIVITY |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SEVERE CONGENITAL NEUTROPENIA | Author keyword | 166 | 82% | 2% | 98 |
2 | CYCLIC NEUTROPENIA | Author keyword | 61 | 78% | 1% | 40 |
3 | HAX 1 | Author keyword | 58 | 75% | 1% | 42 |
4 | ACTIVE PARTICLES | Author keyword | 39 | 68% | 1% | 34 |
5 | COMPLEX BIOSYST MODELING | Address | 36 | 71% | 1% | 29 |
6 | HARVARD MIT HST ATHINOULA A MARTINOS BIOMED I | Address | 32 | 80% | 0% | 20 |
7 | ELANE | Author keyword | 30 | 100% | 0% | 12 |
8 | ELA2 | Author keyword | 27 | 92% | 0% | 11 |
9 | CONGENITAL NEUTROPENIA | Author keyword | 26 | 56% | 1% | 31 |
10 | G6PC3 | Author keyword | 25 | 77% | 0% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SEVERE CONGENITAL NEUTROPENIA | 166 | 82% | 2% | 98 | Search SEVERE+CONGENITAL+NEUTROPENIA | Search SEVERE+CONGENITAL+NEUTROPENIA |
2 | CYCLIC NEUTROPENIA | 61 | 78% | 1% | 40 | Search CYCLIC+NEUTROPENIA | Search CYCLIC+NEUTROPENIA |
3 | HAX 1 | 58 | 75% | 1% | 42 | Search HAX+1 | Search HAX+1 |
4 | ACTIVE PARTICLES | 39 | 68% | 1% | 34 | Search ACTIVE+PARTICLES | Search ACTIVE+PARTICLES |
5 | ELANE | 30 | 100% | 0% | 12 | Search ELANE | Search ELANE |
6 | ELA2 | 27 | 92% | 0% | 11 | Search ELA2 | Search ELA2 |
7 | CONGENITAL NEUTROPENIA | 26 | 56% | 1% | 31 | Search CONGENITAL+NEUTROPENIA | Search CONGENITAL+NEUTROPENIA |
8 | G6PC3 | 25 | 77% | 0% | 17 | Search G6PC3 | Search G6PC3 |
9 | KOSTMANN SYNDROME | 22 | 68% | 0% | 19 | Search KOSTMANN+SYNDROME | Search KOSTMANN+SYNDROME |
10 | AVASCULAR TUMOR GROWTH | 21 | 90% | 0% | 9 | Search AVASCULAR+TUMOR+GROWTH | Search AVASCULAR+TUMOR+GROWTH |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYCLICAL NEUTROPENIA | 134 | 96% | 1% | 43 |
2 | NONLINEAR SIMULATION | 118 | 83% | 1% | 67 |
3 | SEVERE CONGENITAL NEUTROPENIA | 101 | 42% | 3% | 184 |
4 | NECROTIC TUMORS | 77 | 96% | 0% | 24 |
5 | CYCLIC NEUTROPENIA | 58 | 53% | 1% | 77 |
6 | ELA2 | 50 | 88% | 0% | 23 |
7 | TUMOR INDUCED ANGIOGENESIS | 49 | 48% | 1% | 76 |
8 | G CSF RECEPTOR | 41 | 56% | 1% | 50 |
9 | INFANTILE GENETIC AGRANULOCYTOSIS | 40 | 77% | 0% | 27 |
10 | MIXED IMMUNOTHERAPY | 38 | 93% | 0% | 14 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATHEMATICAL BIOSCIENCES AND ENGINEERING | 12 | 13% | 1% | 84 |
2 | MATHEMATICAL MODELLING OF NATURAL PHENOMENA | 10 | 13% | 1% | 71 |
3 | MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA | 5 | 14% | 1% | 32 |
4 | JOURNAL OF BIOLOGICAL DYNAMICS | 4 | 16% | 0% | 21 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
On the interplay between mathematics and biology Hallmarks toward a new systems biology | 2015 | 9 | 122 | 43% |
Dissecting cancer through mathematics: from the cell to the animal model | 2010 | 89 | 72 | 69% |
On the foundations of cancer modelling: Selected topics, speculations, and perspectives | 2008 | 138 | 146 | 67% |
Simulating cancer growth with multiscale agent-based modeling | 2015 | 3 | 73 | 53% |
Nonlinear modelling of cancer: bridging the gap between cells and tumours | 2010 | 100 | 443 | 60% |
Integrative mathematical oncology | 2008 | 108 | 44 | 73% |
Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice | 2015 | 2 | 15 | 67% |
Systems oncology: Towards patient-specific treatment regimes informed by multiscale mathematical modelling | 2015 | 2 | 52 | 65% |
Multiscale Cancer Modeling | 2011 | 62 | 100 | 56% |
Mathematical models of avascular tumor growth | 2007 | 146 | 107 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMPLEX BIOSYST MODELING | 36 | 71% | 0.5% | 29 |
2 | HARVARD MIT HST ATHINOULA A MARTINOS BIOMED I | 32 | 80% | 0.4% | 20 |
3 | QUANTITAT SCI BIOMED | 17 | 62% | 0.3% | 18 |
4 | PROJET BANG | 10 | 73% | 0.1% | 8 |
5 | IN SILICO ONCOL GRP | 8 | 75% | 0.1% | 6 |
6 | MATH MED | 7 | 29% | 0.4% | 21 |
7 | HARVARD MIT HST | 7 | 67% | 0.1% | 6 |
8 | UNIV CRETE | 6 | 80% | 0.1% | 4 |
9 | SEVERE CHRON NEUTROPENIA INT REGISTRY | 6 | 71% | 0.1% | 5 |
10 | THEORET MODELLING MED | 6 | 43% | 0.2% | 10 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000013916 | KELLER SEGEL MODEL//KELLER SEGEL SYSTEM//BIOCONVECTION |
2 | 0.0000012164 | PERMANENCE//GLOBAL ATTRACTIVITY//GLOBAL STABILITY |
3 | 0.0000009294 | BNCT//BORON NEUTRON CAPTURE THERAPY//TIRAPAZAMINE |
4 | 0.0000007846 | EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR |
5 | 0.0000007149 | EXPONENTIAL DICHOTOMY//ALMOST AUTOMORPHIC//PIECEWISE CONSTANT ARGUMENT |
6 | 0.0000006650 | GOOD FUNCTION//TURNPIKE PROPERTY//VINTAGE CAPITAL MODELS |
7 | 0.0000006619 | NEUROCHEM NEUROBIOL//GLIA MATURATION FACTOR//GLIA MATURATION FACTOR GMF |
8 | 0.0000006562 | GEMININ//DNA REPLICATION//CDC6 |
9 | 0.0000005154 | ORBIT FLIP//HOPF BIFURCATION//DOUBLE HOPF BIFURCATION |
10 | 0.0000004668 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |